We are live on ! Find out more
DA

DSC Advisors Portfolio holdings

AUM $11M
1-Year Est. Return 5.88%
This Fund
S&P 500
This Quarter Est. Return
+6.61%
1 Year Est. Return
+5.88%
3 Year Est. Return
+3.18%
5 Year Est. Return
+39.43%
10 Year Est. Return
+114.64%
AUM
$66.7M
AUM Growth
-$47.9M
Cap. Flow
-$50.8M
Cap. Flow %
-76.22%
Top 10 Hldgs %
93.26%
Holding
35
New
13
Increased
8
Reduced
5
Closed
7

Top Buys

1
ABT icon
Abbott
ABT
+$4.41M
2
CVS icon
CVS Health
CVS
+$1.63M
3
EHTH icon
eHealth
EHTH
+$1.5M
4
TEVA icon
Teva Pharmaceuticals
TEVA
+$1.05M
5
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$706K

Top Sells

1
RCM
R1 RCM Inc. Common Stock
RCM
+$2.42M
2
TBT icon
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
+$280K
3
MSOS icon
AdvisorShares Pure US Cannabis ETF
MSOS
+$156K
4
DISH
DISH Network Corp.
DISH
+$140K
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$69.1K

Sector Composition

1 Healthcare 54.06%
2 Industrials 23.27%
3 Communication Services 9.83%
4 Financials 5.81%
5 Technology 2.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RCM
1
DELISTED
R1 RCM Inc. Common Stock
RCM
$15.5M 23.27%
841,000
-149,000
-15% -$2.42M
CVS icon
2
CVS Health
CVS
$137B
$10.6M 15.89%
153,237
+22,957
+18% +$1.63M
ZBH icon
3
Zimmer Biomet
ZBH
$17.6B
$9.1M 13.65%
62,534
+5
+0% +$679
BMRN icon
4
BioMarin Pharmaceuticals
BMRN
$11.5B
$8.67M 13%
100,000
+7,500
+8% +$706K
GOOG icon
5
Alphabet (Google) Class C
GOOG
$4.22T
$5.56M 8.34%
46,000
– –
ABT icon
6
Abbott
ABT
$175B
$4.52M 6.77%
+41,415
New +$4.41M
EHTH icon
7
eHealth
EHTH
$47.3M
$3.06M 4.58%
380,000
+187,500
+97% +$1.5M
TEVA icon
8
Teva Pharmaceuticals
TEVA
$37.3B
$2.33M 3.5%
310,000
+130,000
+72% +$1.05M
BMRN icon
9
PUT
BioMarin Pharmaceuticals
BMRN
$11.5B
$2.17M 3.25%
+25,000
New +$2.35M
ZVRA icon
10
CALL
Zevra Therapeutics
ZVRA
$755M
$672K 1.01%
+131,700
New +$710K
VYNE icon
11
VYNE Therapeutics
VYNE
$25.4M
$467K 0.7%
115,000
– –
MSFT icon
12
Microsoft
MSFT
$2.93T
$365K 0.55%
1,073
-177
-14% -$55.5K
GOOGL icon
13
Alphabet (Google) Class A
GOOGL
$4.23T
$343K 0.51%
2,865
-600
-17% -$69.1K
META icon
14
Meta Platforms (Facebook)
META
$1.64T
$342K 0.51%
1,192
-153
-11% -$37.8K
V icon
15
Visa
V
$682B
$306K 0.46%
1,290
+245
+23% +$56.1K
MA icon
16
Mastercard
MA
$480B
$299K 0.45%
759
+137
+22% +$51.4K
ADBE icon
17
Adobe
ADBE
$94.3B
$261K 0.39%
+534
New +$215K
ACN icon
18
Accenture
ACN
$87.9B
$251K 0.38%
+813
New +$236K
ZVRA icon
19
Zevra Therapeutics
ZVRA
$755M
$250K 0.38%
+49,100
New +$265K
CRM icon
20
Salesforce
CRM
$140B
$250K 0.38%
1,184
+130
+12% +$26.5K
AAPL icon
21
Apple
AAPL
$4.9T
$231K 0.35%
1,190
-218
-15% -$38K
ORCL icon
22
Oracle
ORCL
$364B
$229K 0.34%
+1,921
New +$199K
NFLX icon
23
Netflix
NFLX
$290B
$229K 0.34%
+5,190
New +$191K
HBI
24
CALL
DELISTED
Hanesbrands
HBI
$227K 0.34%
+50,000
New +$229K
BRK.B icon
25
Berkshire Hathaway Class B
BRK.B
$1.06T
$214K 0.32%
+628
New +$205K
1
2

Similar funds

RJTCONH
Raymond James Trust Company of New Hampshire Portsmouth, New Hampshire $12.1M AUM 28.84% 1-Year Est. Return
HSC
Harbor Spring Capital New York $12.3M AUM
BGC
Birch Grove Capital New York $9.51M AUM 0.22% 1-Year Est. Return
ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
AG
Arctis Global San Juan, Puerto Rico $14.5M AUM 58.16% 1-Year Est. Return
RVM
RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return
JDR
Jay D. Rosenbaum $6.69M AUM 4.68% 1-Year Est. Return
KM
Kabouter Management Chicago, Illinois $15.6M AUM 16.79% 1-Year Est. Return

DSC Advisors's Q2 2023 Portfolio in Review

As of Q2 2023, DSC Advisors held 35 positions worth $66.7M, down 42% from $115M the previous quarter. Its ten largest holdings account for 93% of the portfolio.

DSC Advisors withdrew a net $50.8M in Q2 2023, closing 7 positions and reducing 5 holdings. Its most notable exit was ProShares Trust UltraShort Lehman 20+ Year Treasury, an estimated $280K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 54% of assets, up from 25% a quarter earlier, followed by Industrials and Communication Services.

Against the trend, DSC Advisors opened a new position in Abbott worth $4.52M.

  • DSC Advisors's largest Q2 2023 buy was Abbott: 41,415 shares worth $4.52M.
  • DSC Advisors added most to CVS Health in Q2 2023, an estimated $1.63M increase.
  • DSC Advisors's biggest Q2 2023 reduction was R1 RCM Inc. Common Stock, cutting an estimated $2.42M.
  • DSC Advisors fully exited ProShares Trust UltraShort Lehman 20+ Year Treasury in Q2 2023, selling an estimated $280K.
  • DSC Advisors's ten largest holdings make up 93% of its $66.7M portfolio in Q2 2023.
  • DSC Advisors opened 13 new positions and closed 7 in Q2 2023.
  • DSC Advisors's portfolio value fell 42% quarter-over-quarter to $66.7M.

Based on DSC Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.